Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

U.S. sues to block Philadelphia safe drug-injection site

The U.S. Justice Department filed a lawsuit seeking to stop a nonprofit in Philadelphia from opening what could become the nation’s first supervised drug-injection site in an effort aimed at addressing opioid abuse.

Read More »

Study links opioid epidemic to painkiller marketing

Researchers are reporting a link between doctor-targeted marketing of opioid products and the increase in U.S. deaths from overdoses.

Read More »

Ex-Insys CEO to plead guilty to opioid kickback scheme

The former chief executive of Insys Therapeutics Inc. agreed to plead guilty to participating in a scheme to bribe doctors.

Read More »

Rapidly taking patients off opioids might not be a good idea, experts say

Forcing patients off opioid painkillers could sometimes do more harm than good, international medical experts warn in an open letter to health authorities.

Read More »

FDA panel backs prescribing overdose reversal drug with opioids

An advisory panel to the U.S. Food and Drug Administration narrowly recommended prescribing the opioid overdose reversal drug naloxone along with addictive painkillers.

Read More »

FDA declines to approve Mallinckrodt’s abuse-deterrent opioid painkiller

The U.S. Food and Drug Administration declined to approve an abuse-deterrent version of Mallinckrodt Plc’s opioid painkiller Roxicodone, saying some parts of the company’s application need further evaluation.

Read More »

Opioid maker Insys paid kickbacks to physician assistant, jury hears

A former Insys Therapeutics Inc. sales representative now married to the drugmaker’s ex-CEO said she arranged to have a physician assistant in New Hampshire receive kickbacks to prescribe patients its addictive fentanyl spray.

Read More »

Trump to sign anti-opioid abuse package

Medical treatment would be more widely available to opioid abusers under a rare bipartisan measure aimed at tackling the U.S. addiction crisis expected to be signed into law by President Trump.

Read More »

FDA staff says AcelRx opioid painkiller is not better than rivals

AcelRx Pharmaceuticals Inc.’s opioid painkiller offers no apparent advantage to currently available therapies, staff reviewers of the U.S. Food and Administration said.

Read More »

Bayer Cutting More Than 200 Jobs in San Francisco Bay Area

German company Bayer AG is laying off 227 staffers at the company’s manufacturing plant in Berkeley, California. Most of the cuts took place on October 3, 2018.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!

Subscribe

Ad Right Bottom